Åmic AB, Uppsala, Sweden
Developing Forecast Technology, a novel, cost-effective, chip-based microfluidics platform for quantitative lateral flow assays using state-of-the-art optical detection system with unencumbered IP portfolio.
Evaluate strategic options for the Company – outright sale vs. ‘go it alone’ OEM supplier with targeted own cardiac marker sales in Europe.
Ortho-Clinical Diagnostics division of Johnson & Johnson Nordic AB, a wholly owned subsidiary of Johnson & Johnson, Inc. (NYSE: JNJ).
Sale of point-of-care diagnostic assets and related intellectual property following carve-out of unrelated intellectual property into a separate legal entity, Sigolis AB. Financial terms were not disclosed.
Acted as Financial Advisor to the Board of Directors and management.
- Prepared marketing materials and compiled electronic data room.
- Devised and managed strategic sales process maintaining competitive tension through-out the process.
- Spearheaded negotiations with several interested parties and ensured favourable financial outcome for shareholders and stakeholders.
